特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

API (原薬) の世界市場

Active Pharmaceutical Ingredient Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 447118
出版日 ページ情報 英文 130 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
API (原薬) の世界市場 Active Pharmaceutical Ingredient Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年02月17日 ページ情報: 英文 130 Pages
概要

当レポートでは、世界のAPI (原薬) 市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
  • 普及率・成長見通しマッピング

第4章 市場力学

  • 市場促進要因分析
  • 市場抑制要因分析

第5章 API市場分析ツール

  • ファイブフォース分析
  • PESTEL分析
  • 主要取引・戦略的提携分析

第6章 API市場:競合分析

  • 最近の発展・影響分析:主要企業別
  • 企業/競合分類
  • 公開企業
  • 民間企業

第7章 API分子の見通し

  • 世界の売上高
  • 主要市場ポジション企業
  • 比較価格分析

第8章 合成タイプ別のビジネス分析

  • 定義・範囲
  • 合成タイプ別の市場シェア分析
  • API市場:合成タイプ別
  • 市場規模・予測・動向分析
  • バイオテクノロジーAPI
  • 合成API

第9章 メーカータイプ別のビジネス分析

  • 定義・範囲
  • メーカータイプ別の市場シェア分析
  • API市場:メーカータイプ別
  • 市場規模・予測・動向分析
  • キャプティブAPI
  • マーチャントAPI

第10章 タイプ別のビジネス分析

  • 定義・範囲
  • タイプ別の市場シェア分析
  • API市場:タイプ別
  • 市場規模・予測・動向分析
  • ジェネリックAPI
  • 革新的API

第11章 応用別のビジネス分析

  • 定義・範囲
  • 応用別の市場シェア分析
  • API市場:応用別
  • 市場規模・予測・動向分析
  • 心臓
  • 腫瘍
  • CNS・神経
  • 整形外科
  • 内分泌
  • 呼吸器
  • 消化器
  • 腎臓
  • 眼科
  • その他

第12章 応用タイプ別のビジネス分析

  • 定義・範囲
  • 応用別の市場シェア分析
  • API市場:応用別
  • 市場規模・予測・動向分析
  • 心臓
  • 腫瘍
  • CNS・神経
  • 整形外科
  • 内分泌
  • 呼吸器
  • 消化器
  • 腎臓
  • 眼科
  • その他

第13章 API市場:地域別の推計・動向分析

  • 定義・範囲
  • 応用別の市場シェア分析
  • API市場:応用別
  • 市場規模・予測・動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第14章 競合情勢

  • 企業プロファイル
    • ABBVIE, INC.
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • BRISTOL-MYERS SQUIBB COMPANY
    • CIPLA INC.
    • MERCK & CO., INC.
    • ALBEMARLE CORPORATION
    • AUROBINDO PHARMA
    • MYLAN N.V.
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • SUN PHARMACEUTICAL INDUSTRIES, LTD.
    • DR. REDDY'S LABORATORIES LTD.
図表

List of Tables

  • TABLE 1 List of abbreviations
  • TABLE 2 North America API market estimates and forecasts, by country, 2015 - 2027 (USD Billion)
  • TABLE 3 North America API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 4 North America biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 5 North America API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 6 North America merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 7 North America API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 8 North America API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 9 North America cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 10 North America oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 11 North America CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 12 North America orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 13 North America endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 14 North America pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 15 North America gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 16 North America nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 17 North America ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 18 North America others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 19 U.S. API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 20 U.S. biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 21 U.S. API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 22 U.S. merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 23 U.S. API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 24 U.S. API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 25 U.S. cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 26 U.S. oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 27 U.S. CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 28 U.S. orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 29 U.S. endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 30 U.S. pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 31 U.S. gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 32 U.S. nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 33 U.S. ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 34 U.S. others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 35 Canada API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 36 Canada biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 37 Canada API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 38 Canada merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 39 Canada API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 40 Canada API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 41 Canada cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 42 Canada oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 43 Canada CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 44 Canada orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 45 Canada endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 46 Canada pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 47 Canada gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 48 Canada nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 49 Canada ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 50 Canada others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 51 Europe API market estimates and forecasts, by country, 2015 - 2027 (USD Billion)
  • TABLE 52 Europe API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 53 Europe biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 54 Europe API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 55 Europe merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 56 Europe API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 57 Europe API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 58 Europe cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 59 Europe oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 60 Europe CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 61 Europe orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 62 Europe endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 63 Europe pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 64 Europe gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 65 Europe nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 66 Europe ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 67 Europe others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 68 Germany API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 69 Germany biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 70 Germany API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 71 Germany merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 72 Germany API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 73 Germany API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 74 Germany cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 75 Germany oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 76 Germany CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 77 Germany orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 78 Germany endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 79 Germany pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 80 Germany gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 81 Germany nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 82 Germany ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 83 Germany others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 84 U.K. API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 85 U.K. biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 86 U.K. API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 87 U.K. merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 88 U.K. API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 89 U.K. API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 90 U.K. cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 91 U.K. oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 92 U.K. CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 93 U.K. orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 94 U.K. endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 95 U.K. pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 96 U.K. gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 97 U.K. nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 98 U.K. ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 99 U.K. others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 100 France API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 101 France biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 102 France API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 103 France merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 104 France API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 105 France API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 106 France cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 107 France oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 108 France CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 109 France orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 110 France endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 111 France pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 112 France gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 113 France nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 114 France ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 115 France others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 116 Italy API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 117 Italy biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 118 Italy API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 119 Italy merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 120 Italy API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 121 Italy API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 122 Italy cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 123 Italy oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 124 Italy CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 125 Italy orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 126 Italy endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 127 Italy pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 128 Italy gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 129 Italy nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 130 Italy ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 131 Italy others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 132 Spain API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 133 Spain biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 134 Spain API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 135 Spain merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 136 Spain API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 137 Spain API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 138 Spain cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 139 Spain oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 140 Spain CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 141 Spain orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 142 Spain endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 143 Spain pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 144 Spain gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 145 Spain nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 146 Spain ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 147 Spain others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 148 Russia API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 149 Russia biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 150 Russia API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 151 Russia merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 152 Russia API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 153 Russia API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 154 Russia cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 155 Russia oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 156 Russia CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 157 Russia orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 158 Russia endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 159 Russia pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 160 Russia gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 161 Russia nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 162 Russia ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 163 Russia others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 164 Asia Pacific market estimates and forecasts, by country, 2015 - 2027 (USD Billion)
  • TABLE 165 Asia Pacific API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 166 Asia Pacific biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 167 Asia Pacific API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 168 Asia Pacific merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 169 Asia Pacific API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 170 Asia Pacific API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 171 Asia Pacific cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 172 Asia Pacific oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 173 Asia Pacific CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 174 Asia Pacific orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 175 Asia Pacific endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 176 Asia Pacific pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 177 Asia Pacific gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 178 Asia Pacific nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 179 Asia Pacific ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 180 Asia Pacific others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 181 Japan API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 182 Japan biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 183 Japan API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 184 Japan merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 185 Japan API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 186 Japan API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 187 Japan cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 188 Japan oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 189 Japan CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 190 Japan orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 191 Japan endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 192 Japan pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 193 Japan gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 194 Japan nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 195 Japan ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 196 Japan others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 197 China API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 198 China biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 199 China API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 200 China merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 201 China API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 202 China API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 203 China cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 204 China oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 205 China CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 206 China orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 207 China endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 208 China pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 209 China gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 210 China nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 211 China ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 212 China others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 213 India API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 214 India biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 215 India API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 216 India merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 217 India API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 218 India API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 219 India cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 220 India oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 221 India CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 222 India orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 223 India endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 224 India pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 225 India gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 226 India nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 227 India ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 228 India others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 229 South Korea API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 230 South Korea biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 231 South Korea API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 232 South Korea merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 233 South Korea API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 234 South Korea API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 235 South Korea cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 236 South Korea oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 237 South Korea CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 238 South Korea orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 239 South Korea endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 240 South Korea pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 241 South Korea gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 242 South Korea nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 243 South Korea ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 244 South Korea others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 245 Australia API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 246 Australia biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 247 Australia API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 248 Australia merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 249 Australia API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 250 Australia API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 251 Australia cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 252 Australia oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 253 Australia CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 254 Australia orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 255 Australia endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 256 Australia pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 257 Australia gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 258 Australia nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 259 Australia ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 260 Australia others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 261 Latin America API market estimates and forecasts, by country, 2015 - 2027 (USD Billion)
  • TABLE 262 Latin America API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 263 Latin America biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 264 Latin America API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 265 Latin America merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 266 Latin America API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 267 Latin America API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 268 Latin America cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 269 Latin America oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 270 Latin America CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 271 Latin America orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 272 Latin America endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 273 Latin America pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 274 Latin America gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 275 Latin America nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 276 Latin America ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 277 Latin America others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 278 Brazil API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 279 Brazil biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 280 Brazil API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 281 Brazil merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 282 Brazil API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 283 Brazil API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 284 Brazil cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 285 Brazil oncology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 286 Brazil CNS and neurology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 287 Brazil orthopedic API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 288 Brazil endocrinology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 289 Brazil pulmonology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 290 Brazil gastroenterology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 291 Brazil nephrology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 292 Brazil ophthalmology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 293 Brazil others market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 294 Mexico API market estimates and forecasts, by type of synthesis, 2015 - 2027 (USD Billion)
  • TABLE 295 Mexico biotech API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 296 Mexico API market estimates and forecasts, by type of manufacturer, 2015 - 2027 (USD Billion)
  • TABLE 297 Mexico merchant API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 298 Mexico API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)
  • TABLE 299 Mexico API market estimates and forecasts, by application, 2015 - 2027 (USD Billion)
  • TABLE 300 Mexico cardiology API market estimates and forecasts, by type, 2015 - 2027 (USD Billion)

List of Figures

  • Fig. 1 API Market Segmentation
  • Fig. 2 Information Procurement
  • Fig. 3 QFD modelling for market share assessment
  • Fig. 4 API Market, 2019
  • Fig. 5 Penetration and growth prospect mapping
  • Fig. 6 API Market Driver Impact
  • Fig. 7 Global percentage of population, by age group, 2050 and 2000
  • Fig. 8 API Market Restraint Impact
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 API market: Type of synthesis outlook and key takeaways
  • Fig. 12 API Market: Type of Synthesis Movement Analysis
  • Fig. 13 Biotech API market estimates and forecast, 2015 - 2027
  • Fig. 14 Monoclonal antibodies market estimates and forecast, 2015 - 2027
  • Fig. 15 Recombinant proteins market estimates and forecast, 2015 - 2027
  • Fig. 16 Vaccines market estimates and forecast, 2015 - 2027
  • Fig. 17 Synthetic API market estimates and forecast, 2015 - 2027
  • Fig. 18 API market: Type of manufacturer outlook and key takeaways
  • Fig. 19 API Market: Type of Manufacturer Movement Analysis
  • Fig. 20 Captive API market estimates and forecast, 2015 - 2027
  • Fig. 21 Merchant API market estimates and forecast, 2015 - 2027
  • Fig. 22 API market: Type outlook and key takeaways
  • Fig. 23 API Market: Type Movement Analysis
  • Fig. 24 Generic APIs market estimates and forecast, 2015 - 2027
  • Fig. 25 Innovative APIs market estimates and forecast, 2015 - 2027
  • Fig. 26 API market: Application outlook and key takeaways
  • Fig. 27 API Market: Application Movement Analysis
  • Fig. 28 Cardiology market estimates and forecast, 2015 - 2027
  • Fig. 29 Oncology market estimates and forecast, 2015 - 2027
  • Fig. 30 CNS & neurology market estimates and forecast, 2015 - 2027
  • Fig. 31 Orthopedics market estimates and forecast, 2015 - 2027
  • Fig. 32 Endocrinology market estimates and forecast, 2015 - 2027
  • Fig. 33 Pulmonology market estimates and forecast, 2015 - 2027
  • Fig. 34 Gastrointestinal disorders market estimates and forecast, 2015 - 2027
  • Fig. 35 Nephrology market estimates and forecast, 2015 - 2027
  • Fig. 36 Ophthalmology market estimates and forecast, 2015 - 2027
  • Fig. 37 Others market estimates and forecast, 2015 - 2027
  • Fig. 38 API market: Regional movement analysis
  • Fig. 39 North America
  • Fig. 40 North America market estimates and forecast, 2015 - 2027
  • Fig. 41 U.S. market estimates and forecast, 2015 - 2027
  • Fig. 42 Canada market estimates and forecast, 2015 - 2027
  • Fig. 43 Europe
  • Fig. 44 Europe market estimates and forecast, 2015 - 2027
  • Fig. 45 Germany market estimates and forecast, 2015 - 2027
  • Fig. 46 U.K. market estimates and forecast, 2015 - 2027
  • Fig. 47 Spain market estimates and forecast, 2015 - 2027
  • Fig. 48 France market estimates and forecast, 2015 - 2027
  • Fig. 49 Italy market estimates and forecast, 2015 - 2027
  • Fig. 50 Russia market estimates and forecast, 2015 - 2027
  • Fig. 51 Asia Pacific
  • Fig. 52 Asia Pacific market estimates and forecast, 2015 - 2027
  • Fig. 53 Japan market estimates and forecast, 2015 - 2027
  • Fig. 54 China market estimates and forecast, 2015 - 2027
  • Fig. 55 India market estimates and forecast, 2015 - 2027
  • Fig. 56 South Korea market estimates and forecast, 2015 - 2027
  • Fig. 57 Australia market estimates and forecast, 2015 - 2027
  • Fig. 58 Latin America
  • Fig. 59 Latin America market estimates and forecast, 2015 - 2027
  • Fig. 60 Brazil market estimates and forecast, 2015 - 2027
  • Fig. 61 Mexico market estimates and forecast, 2015 - 2027
  • Fig. 62 Argentina market estimates and forecast, 2015 - 2027
  • Fig. 63 Middle East & Africa
  • Fig. 64 MEA market estimates and forecast, 2015 - 2027
  • Fig. 65 South Africa market estimates and forecast, 2015 - 2027
  • Fig. 66 Saudi Arabia market estimates and forecast, 2015 - 2027
  • Fig. 67 UAE market estimates and forecast, 2015 - 2027
  • Fig. 68 Strategic framework
目次
Product Code: GVR-1-68038-348-5

The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth.

A steady rise in consumer demand for APIs, especially in developing and under-developed countries, increases the adoption of these products. In addition, strategic collaborations play a key role in the adoption of these ingredients in various regions. For instance, in February 2019, Cipla Inc. partnered with Wellthy Therapeutics Private Limited to combine digital therapeutics and pharmacotherapy for better patient outcomes in cardiovascular diseases and diabetes.

Private and public initiatives to manufacture active pharmaceutical ingredients within their countries, especially in developing countries such as India, is expected to drive the growth of the market. For instance, API production in India is promoted under the "Make in India" initiative.

Presence of prominent players and increasing government initiatives for the development of pharmaceuticals in various regions are also expected to boost the market growth. Increasing consumer awareness and demand for economical and effective treatment strategies, especially in Asia Pacific and Middle East and Africa, are driving the sales channels. In addition, high adoption and growing usage of online pharmacies are likely to drive the e-commerce sales of APIs.

The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. For instance, in March 2019, Dr. Reddy's Laboratories Ltd. launched XCEED-a B2B customer service portal. The platform was designed to manage the growing demand for generic active pharmaceutical ingredients by significantly increasing operational efficiency.

Further key findings from the study suggest:

On the basis of type of synthesis, the synthetic segment dominated the active pharmaceutical ingredients market in 2019 owing to easy availability of raw materials and easier protocols in place for the synthesis of these molecules

The biotech segment is estimated to register the highest CAGR owing to higher efficiency of these molecules and increasing demand for biopharmaceuticals

Captive manufacturers held the largest share in 2019 due to easy availability of raw materials

The merchant manufacturers segment is estimated to witness a lucrative CAGR over the forecast period

The generic segment is estimated to register the highest CAGR over the forecast period. The segment is driven by factors such as lower cost and expiration of patents of branded drugs

Asia Pacific is estimated to register a significant CAGR of 8.0% owing to the increasing number of pharmaceutical manufacturing plants in the region

Some of the key players in the API market are Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim International GmbH; AbbVie Inc.; Merck & Co., Inc.; Cipla Inc.; Albemarle Corporation; Dr. Reddy's Laboratories Ltd.; Bristol-Myers Squibb Company; Aurobindo Pharma; and Sun Pharmaceutical Industries Ltd.

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Validation & Publishing
  • 1.7 Geographic Scope & Assumptions
  • 1.8 Region-Wise Market Calculation
    • 1.8.1 Region-Wise Market: Base Estimates
  • 1.9 Market Cagr Calculation
    • 1.9.1 Region Based Segment Share Calculation

Chapter 2 Executive Summary

  • 2.1 API Market Outlook
  • 2.2 API Market: - Segment Outlook
  • 2.3 API Market: -Competitive Insights
  • 2.4 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping

Chapter 4 Market Dynamics

  • 4.1 Market Driver Analysis
    • 4.1.1 Growing Geriatric Population Base
    • 4.1.2 Growing Prevalence Of Target Diseases Such As Hospital Acquired Infections, Genetic, Cardiovascular And Neurological Diseases
    • 4.1.3 Increasing Preference For Targeted Therapy Approach In Cancer Treatment
    • 4.1.4 Increasing Preference For Outsourcing APIs
  • 4.2 Market Restraint Analysis
    • 4.2.1 Large Capital Investments And Production Cost
    • 4.2.2 Stringent Safety And Handling Regulations Regarding APIs

Chapter 5 API Market Analysis Tools

  • 5.1 Industry Analysis - Porter's
    • 5.1.1 Supplier Power: Moderate Due To Large Number Of Diagnostic Test Manufacturers
    • 5.1.2 Buyer Power: Moderate Due To Presence Of Players Entering Into Long-Term Contract
    • 5.1.3 Substitution Threat: Low Due To No/ Less External Substitutes
    • 5.1.4 Threat From New Entrant: Moderate Due To Brand Recognition Of The Existing Players
    • 5.1.5 Competitive Rivalry: High Due To Increasing Mergers & Acquisitions By Major Players
  • 5.2 Pestel Analysis
    • 5.2.1 Political Landscape
    • 5.2.2 Environmental Landscape
    • 5.2.3 Social Landscape
    • 5.2.4 Technology Landscape
    • 5.2.5 Legal Landscape
  • 5.3 Major Deals & Strategic Alliances Analysis
    • 5.3.1 Joint Ventures
    • 5.3.2 Mergers & Acquisitions
    • 5.3.3 Licensing & Partnership
    • 5.3.4 Technology Collaborations
    • 5.3.5 Strategic Divestments

Chapter 6 API Market - Competitive Analysis

  • 6.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 6.3 Public Companies
    • 6.3.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
    • 6.3.2 Company Market Share/Ranking, By Region
    • 6.3.3 Competitive Dashboard Analysis
    • 6.3.4 Market Differentiators
    • 6.3.5 Synergy Analysis: Major Deals & Strategic Alliances
  • 6.4 Private Companies
    • 6.4.1 List Of Key Emerging Companies
    • 6.4.2 Regional Network Map
    • 6.4.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)

Chapter 7 API Molecules Outlook

  • 7.1 Global Sales (2015-2019)
  • 7.2 Companies With Leading Market Position For API Molecules
    • 7.2.1 Amoxicillin
    • 7.2.2 Azithromycin
    • 7.2.3 Bleomycin
    • 7.2.4 Caspofungin
    • 7.2.5 Clarithromycin
    • 7.2.6 Clavulanic Acid
    • 7.2.7 Clindamycin
    • 7.2.8 Compactin (Mevastatin)
    • 7.2.9 Cyclosporin
    • 7.2.10 Dactinomycin
    • 7.2.11 Daptomycin
    • 7.2.12 Demeclocycline
    • 7.2.13 Doxycycline
    • 7.2.14 Erythromycin
    • 7.2.15 Ivermectin (Avermectin)
    • 7.2.16 Lovastatin
    • 7.2.17 Micafungin
    • 7.2.18 Minocycline
    • 7.2.19 Mitomycin
    • 7.2.20 Mycophenolic Acid
    • 7.2.21 Pneumocandin B0
    • 7.2.22 Polymyxin
    • 7.2.23 Pravastatin
    • 7.2.24 Rapamycin (Sirolimus)
    • 7.2.25 Simvastatin
    • 7.2.26 Steroids
    • 7.2.27 Tacrolimus
    • 7.2.28 Tetracycline
    • 7.2.29 Tigecycline
    • 7.2.30 Tobramycin
    • 7.2.31 Vancomycin
  • 7.3 Comparative Price Analysis Of The Above-Mentioned Molecules

Chapter 8 Type Of Synthesis Business Analysis

  • 8.1. Definitions & Scope
  • 8.2. Type of Synthesis Market Share Analysis, 2019 & 2027
  • 8.3. API Market, by Type of Synthesis, 2015 to 2027
  • 8.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
  • 8.5 Biotech API
    • 8.5.1 Biotech API Market, 2015 - 2027 (USD Billion)
    • 8.5.2 Monoclonal Antibodies
      • 8.5.2.1 Monoclonal Antibodies Market, 2015 - 2027 (USD Billion)
    • 8.5.3 Recombinant Proteins
      • 8.5.3.1 Recombinant Proteins Market, 2015 - 2027 (USD Billion)
    • 8.5.4 Vaccines
      • 8.5.4.1 Vaccines Market, 2015 - 2027 (USD Billion)
  • 8.6 Synthetic API
    • 8.6.1 Synthetic API Market, 2015 - 2027 (USD Billion)

Chapter 9 Type Of Manufacturer Business Analysis

  • 9.1. Definitions & Scope
  • 9.2. Type Of Manufacturer Market Share Analysis, 2019 & 2027
  • 9.3. API Market, By Type Of Manufacturer, 2015 To 2027
  • 9.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
  • 9.5 Captive API
    • 9.5.1 Captive API Market, 2015 - 2027 (USD Billion)
  • 9.6 Merchant API
    • 9.6.1 Merchant API Market, 2015 - 2027 (USD Billion)

Chapter 10 Type Business Analysis

  • 10.1. Definitions & Scope
  • 10.2. Type Market Share Analysis, 2019 & 2027
  • 10.3. API Market, By Type, 2015 To 2027
  • 10.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
  • 10.5 Generic APIs
    • 10.5.1 Generic API Market, 2015 - 2027 (USD Billion)
  • 10.6 Innovative APIs
    • 10.6.1 Innovative API Market, 2015 - 2027 (USD Billion)

Chapter 11 Application Business Analysis

  • 11.1. Definitions & Scope
  • 11.2. Application Market Share Analysis, 2019 & 2027
  • 11.3. API Market, By Application, 2015 To 2027
  • 11.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
  • 11.5 Cardiology
    • 11.5.1 Cardiology Market, 2015 - 2027 (USD Billion)
  • 11.6 Oncology
    • 11.6.1 Oncology Market, 2015 - 2027 (USD Billion)
  • 11.7 Cns & Neurology
    • 11.7.1 Cns & Neurology Market, 2015 - 2027 (USD Billion)
  • 11.8 Orthopedics
    • 11.8.1 Orthopedics Market, 2015 - 2027 (USD Billion)
  • 11.9 Endocrinology
    • 11.9.1 Endocrionology Market, 2015 - 2027 (USD Billion)
  • 11.10 Pulmonology
    • 11.10.1 Pulmonology Market, 2015 - 2027 (USD Billion)
  • 11.11 Gastroenterology
    • 11.11.1 Gastrointestinal Disorders Market, 2015 - 2027 (USD Billion)
  • 11.12 Nephrology
    • 11.12.1 Nephrology Market, 2015 - 2027 (USD Billion)
  • 11.13 Ophthalmology
    • 11.13.1 Opthalmology Market, 2015 - 2027 (USD Billion)
  • 11.14 Others
    • 11.14.1 Others Market, 2015 - 2027 (USD Billion)

Chapter 12 Application, By Type Business Analysis (Cross-Matrix)

  • 12.1. Definitions & Scope
  • 12.2. Application Market Share Analysis, 2019 & 2027
  • 12.3. API Market, By Application, 2015 To 2027
  • 12.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
  • 12.5 Cardiology
    • 12.5.1 Generic
      • 12.5.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.5.2 Innovative
      • 12.5.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.6 Oncology
    • 12.6.1 Generic
      • 12.6.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.6.2 Innovative
      • 12.6.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.7 Cns & Neurology
    • 12.7.1 Generic
      • 12.7.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.7.2 Innovative
      • 12.7.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.8 Orthopedics
    • 12.8.1 Generic
      • 12.8.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.8.2 Innovative
      • 12.8.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.9 Endocrinology
    • 12.9.1 Generic
      • 12.9.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.9.2 Innovative
      • 12.9.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.10 Pulmonology
    • 12.10.1 Generic
      • 12.10.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.10.2 Innovative
      • 12.10.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.11 Gastroenterology
    • 12.11.1 Generic
      • 12.11.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.11.2 Innovative
      • 12.11.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.12 Nephrology
    • 12.12.1 Generic
      • 12.12.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.12.2 Innovative
      • 12.12.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.13 Ophthalmology
    • 12.13.1 Generic
      • 12.13.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.13.2 Innovative
      • 12.13.2.1 Innovative Market, 2015 - 2027 (USD Billion)
  • 12.14 Others
    • 12.14.1 Generic
      • 12.14.1.1 Generic Market, 2015 - 2027 (USD Billion)
    • 12.14.2 Innovative
      • 12.14.2.1 Innovative Market, 2015 - 2027 (USD Billion)

Chapter 13 API Market: Regional Estimates & Trend Analysis

  • 13.1. Definitions & Scope
  • 13.2. Application Market Share Analysis, 2019 & 2027
  • 13.3. API Market, By Application, 2015 To 2027
  • 13.4. Market Size & Forecasts And Trend Analyses, 2015 To 2027 For The Following,
  • 13.5. North America
    • 13.5.1 North America Market Estimates And Forecast, 2015 - 2027
    • 13.5.2 U.S.
      • 13.5.2.1 U.S. Market Estimates And Forecast, 2015 - 2027
    • 13.5.3 Canada
      • 13.5.3.1 Canada Market Estimates And Forecast, 2015 - 2027
  • 13.6. Europe
    • 13.6.1 Europe Market Estimates And Forecast, 2015 - 2027
    • 13.6.2 Germany
      • 13.6.2.1 Germany Market Estimates And Forecast, 2015 - 2027
    • 13.6.3 U.K.
      • 13.6.3.1 U.K. Market Estimates And Forecast, 2015 - 2027
    • 13.6.4 Spain
      • 13.6.4.1 Spain Market Estimates And Forecast, 2015 - 2027
    • 13.6.5 France
      • 13.6.5.1 France Market Estimates And Forecast, 2015 - 2027
    • 13.6.6 Italy
      • 13.6.6.1 Italy Market Estimates And Forecast, 2015 - 2027
  • 13.7. Asia Pacific
    • 13.7.1 Asia Pacific Market Estimates And Forecast, 2015 - 2027
    • 13.7.2 Japan
      • 13.7.2.1 Japan Market Estimates And Forecast, 2015 - 2027
    • 13.7.3 China
      • 13.7.3.1 China Market Estimates And Forecast, 2015 - 2027
    • 13.7.4 India
      • 13.7.4.1 India Market Estimates And Forecast, 2015 - 2027
    • 13.7.5 South Korea
      • 13.7.5.1 South Korea Market Estimates And Forecast, 2015 - 2027
    • 13.7.6 Australia
      • 13.7.6.1 Australia Market Estimates And Forecast, 2015 - 2027
  • 13.8. Latin America
    • 13.8.1 Latin America Market Estimates And Forecast, 2015 - 2027
    • 13.8.2 Brazil
      • 13.8.2.1 Brazil Market Estimates And Forecast, 2015 - 2027
    • 13.8.3 Mexico
      • 13.8.3.1 Mexico Market Estimates And Forecast, 2015 - 2027
    • 13.8.4 Argentina
      • 13.8.4.1 Argentina Market Estimates And Forecast, 2015 - 2027
  • 13.9. Mea
    • 13.9.1 Mea Market Estimates And Forecast, 2015 - 2027
    • 13.9.2 South Africa
      • 13.9.2.1 South Africa Market Estimates And Forecast, 2015 - 2027
    • 13.9.3 Saudi Arabia
      • 13.9.3.1 Saudi Arabia Market Estimates And Forecast, 2015 - 2027
    • 13.9.4 UAE
      • 13.9.4.1 UAE Market Estimates And Forecast, 2015 - 2027
      • 13.10.Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 13.10.1. North America
    • 13.10.2. Europe
    • 13.10.3. Asia Pacific
    • 13.10.4. Latin America
    • 13.10.5. Middle East & Africa

Chapter 14 Competitive Landscape

  • 14.1 Company Profiles
    • 14.1.1 ABBVIE, INC.
      • 14.1.1.1 Company overview
      • 14.1.1.2 Financial performance
      • 14.1.1.3 Product benchmarking
      • 14.1.1.4 Strategic initiatives
    • 14.1.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 14.1.2.1 Company overview
      • 14.1.2.2 Financial performance
      • 14.1.2.3 Product benchmarking
      • 14.1.2.4 Strategic initiatives
    • 14.1.3 BRISTOL-MYERS SQUIBB COMPANY
      • 14.1.3.1 Company overview
      • 14.1.3.2 Financial performance
      • 14.1.3.3 Product benchmarking
      • 14.1.3.4 Strategic initiatives
    • 14.1.4 CIPLA INC.
      • 14.1.4.1 Company overview
      • 14.1.4.2 Financial performance
      • 14.1.4.3 Product benchmarking
      • 14.1.4.4 Strategic initiatives
    • 14.1.5 MERCK & CO., INC.
      • 14.1.5.1 Company overview
      • 14.1.5.2 Financial performance
      • 14.1.5.3 Product benchmarking
      • 14.1.5.4 Strategic initiatives
    • 14.1.6 ALBEMARLE CORPORATION
      • 14.1.6.1 Company overview
      • 14.1.6.2 Financial overview
      • 14.1.6.3 Product benchmarking
      • 14.1.6.4 Strategic initiatives
    • 14.1.7 AUROBINDO PHARMA
      • 14.1.7.1 Company overview
      • 14.1.7.2 Financial overview
      • 14.1.7.3 Product benchmarking
      • 14.1.7.4 Strategic initiatives
    • 14.1.8 MYLAN N.V.
      • 14.1.8.1 Company overview
      • 14.1.8.2 Financial overview
      • 14.1.8.3 Product benchmarking
      • 14.1.8.4 Strategic initiatives
    • 14.1.9 TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • 14.1.9.1 Company overview
      • 14.1.9.2 Financial overview
      • 14.1.9.3 Product benchmarking
      • 14.1.9.4 Strategic initiatives
    • 14.1.10 SUN PHARMACEUTICAL INDUSTRIES, LTD.
      • 14.1.10.1 Company overview
      • 14.1.10.2 Financial overview
      • 14.1.10.3 Product benchmarking
      • 14.1.10.4 Strategic initiatives
    • 14.1.11 DR. REDDY'S LABORATORIES LTD.
      • 14.1.11.1 Company overview
      • 14.1.11.2 Financial overview
      • 14.1.11.3 Product benchmarking
      • 14.1.11.4 Strategic initiatives